Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05706610 · ClinicalTrials.gov registry record · NA

A Pilot Feasibility Trial of a Tailored Intervention to Improve Adherence in Adolescents and Young Adults With Cancer

A NA study of Cancer and Adherence, Medication, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
NA
Development phase
70
Enrollment target
3
Study locations

NCT05706610: Completed NA study of Cancer and Adherence, Medication, sponsored by Children's Hospital Medical Center, Cincinnati.

NCT05706610 is a NA study of Cancer and Adherence, Medication that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 70 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05706610, a NA study of Cancer and Adherence, Medication, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target
3
Study locations

Study Summary

A pilot feasibility randomized clinical trial comparing a tailored intervention to uniform standard of care will be conducted. A total of 40 AYAs with cancer will be randomized to one of the two programs. Data will be collected to explore the hypotheses that the intervention meets pre-established enrollment, retention, fidelity, and data completion feasibility criteria and that AYAs will rate the intervention as easy to use and acceptable.

Primary Outcome

Percent of approached eligible participants enrolling in the study

Interventions

  • BEHAVIORAL Tailored Program
  • BEHAVIORAL Feedback Program

Study Locations (3)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Tennessee

  • St Jude Children's Research Hospital - Memphis

Washington

  • Seattle Children's Hospital - Seattle

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2023-02-23
Est. Completion 2025-03-31
Phase NA

What the finished NCT05706610 record still lists

NCT05706610 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Tailored Program is the first listed.

NCT05706610 reports a single indexed study location in Ohio, Tennessee, Washington.

Frequently Asked Questions

What is clinical trial NCT05706610 about?

NCT05706610 is a clinical study titled "A Pilot Feasibility Trial of a Tailored Intervention to Improve Adherence in Adolescents and Young Adults With Cancer". A pilot feasibility randomized clinical trial comparing a tailored intervention to uniform standard of care will be conducted. A total of 40 AYAs with cancer will be randomized to one of the two programs. Data will be collected to explore the hypotheses that the intervention meets pre-established en...

What is the current status of trial NCT05706610?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2023-02-23. Estimated completion is 2025-03-31.

What conditions does trial NCT05706610 study?

This clinical trial studies the following conditions: Cancer, Adherence, Medication.

What interventions are being tested in trial NCT05706610?

The interventions under investigation include: Tailored Program (BEHAVIORAL), Feedback Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05706610?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05706610 being conducted?

This trial has 3 study locations across Ohio, Tennessee, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05706610's enrollment target sits among peer trials

70 373rd of 615 higher than 236 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05706610, the US trial registry maintained by the National Library of Medicine. NCT05706610 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.